Spirulina and Voltage-Gated Ion Channels: Nav, Kv, and Cardiac/Neuronal Electrophysiology

Voltage-Gated Sodium Channels (Nav): Structure and Gating

Voltage-gated Na+ channels (Nav1.1-1.9/SCN1A-9A plus Nav1.5/SCN5A cardiac) are alpha-subunit pore-forming proteins with four homologous domains (DI-DIV), each containing six transmembrane segments (S1-S6). S4 is the voltage sensor (positively charged Arg/Lys at every third position), moving outward upon depolarisation to open the pore. Fast inactivation occurs via the DIII-DIV linker (IFM motif, binding the inactivation gate). Nav1.5 (cardiac) is critical for the upstroke of cardiac action potential (Phase 0, ~350 mV/ms), conduction velocity, and QRS morphology. Nav1.7 (DRG neurons, nociception) mutations cause channelopathies including congenital insensitivity to pain (GoF/LoF).

PCB and Na+ Channel Modulation

Studies in isolated cardiomyocytes and neuronal preparations suggest phycocyanin extracts modestly reduce peak INa (sodium current) amplitude and shift the steady-state inactivation curve toward more negative potentials (use-dependent channel inactivation), reducing peak excitability at high firing rates. This effect is analogous to class Ib antiarrhythmic drugs (lidocaine, mexiletine, use-dependent Nav block). The mechanism may involve direct PCB interaction with the Nav local anaesthetic binding site (S6 segments IVS6/IIIS6) or indirect redox modulation (Nav Cys373 in the DI-DII linker is redox-sensitive, oxidation shifting inactivation). Nrf2-driven reduction of Nav Cys oxidation could normalise channel gating in oxidative cardiac/neuronal stress.

Voltage-Gated K+ Channels: Kv1.5, hERG, and Repolarisation

Repolarisation of the cardiac action potential relies on K+ channels: IKr (KCNH2/hERG, rapid delayed rectifier), IKs (KCNQ1/KCNE1, slow), IKur (KCNA5/Kv1.5, ultra-rapid, atrial-specific), and IK1 (KCNJ2/Kir2.1, inward rectifier). hERG blockade (by drugs, hypokalaemia, oxidative stress) prolongs QT interval and risks torsades de pointes. Kv1.5 is the atrial-dominant channel; its blockade (by some antiarrhythmics) prevents atrial fibrillation. ROS oxidise hERG channel extracellular cysteines (Cys3/Cys4 in the N-terminal PAS domain), causing channel dysfunction. Spirulina's Nrf2-driven antioxidant protection of cardiac K+ channels from ROS-mediated dysfunction is consistent with anti-arrhythmic effects reported in doxorubicin cardiotoxicity models.

Kv7 (KCNQ) Channels and PIP2 Regulation

Kv7.1-7.5 (KCNQ1-5) are voltage-gated K+ channels requiring PIP2 for gating. KCNQ1/KCNE1 (IKs) and KCNQ2/KCNQ3 (M-current/IKM, neuronal) are regulated by phospholipase C-coupled receptors: Gq-PLC-beta hydrolysis of PIP2 suppresses IKM, increasing neuronal excitability (muscarinic M1/M3 receptor effect). Spirulina's modulation of PIP2 metabolism (via phosphoinositide signalling mechanisms) and NF-kB- driven Gq-coupled receptor expression could indirectly influence Kv7 activity, though direct spirulina-Kv7 electrophysiology studies are lacking.

Calcium-Activated K+ Channels (BKCa) and Vasodilation

Large-conductance calcium-activated K+ channels (BKCa/KCNMA1/MaxiK) are activated by membrane depolarisation and intracellular Ca2+, coupling Ca2+ signals to K+ efflux, membrane hyperpolarisation, and vascular smooth muscle relaxation. BKCa is activated by: (1) direct Ca2+ binding (RCK1/RCK2 Ca2+ bowl domains); (2) S-nitrosylation (Cys911, by eNOS-derived NO); (3) PKA phosphorylation; (4) haem (direct activation by CO from HO-1). Spirulina's Nrf2-HO-1-CO activation of vascular smooth muscle BKCa provides a mechanism for vasodilation and blood pressure reduction independent of eNOS/NO, consistent with clinical blood pressure lowering data.

Nav1.7 in Neuropathic Pain: Neuroinflammation Connection

Nav1.7 (SCN9A) in DRG nociceptors is sensitised by inflammatory mediators: PGE2 (EP1/EP2/PKA phosphorylating Nav1.7 Ser551), TNF-alpha (TNFR1/p38-MAPK/ ATF3-Nav1.7 transcription), and NGF (TrkA/PI3K sensitising Nav1.7 current). Spirulina's combined NF-kB/TNF-alpha and eicosanoid (PGE2) suppression would reduce Nav1.7 sensitisation in inflamed nociceptors, providing a mechanistically grounded basis for observed analgesic effects in inflammatory pain animal models and consistent with reduced pain scores in some human spirulina trials.